Published in Clin Exp Immunol on November 01, 1974
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest (1976) 1.41
Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol (1977) 1.39
Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol (1977) 1.36
Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest (1984) 1.32
Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest (1982) 1.19
Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Clin Exp Immunol (1976) 1.17
Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. J Clin Invest (1979) 1.09
Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest (1994) 1.01
Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus. J Clin Invest (1979) 0.95
Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes. J Clin Invest (1977) 0.94
Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte. J Clin Invest (1983) 0.87
Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus. Ann Rheum Dis (1975) 0.78
STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM. J Exp Med (1965) 8.81
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest (1973) 2.84
Transplantation antigens: introductory symposium. Mixed leukocyte cultures and HL-A antigens. I. Reactivity of young fetuses, newborns and mothers at delivery. Transplant Proc (1971) 2.63
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest (1973) 2.19
Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders. Arthritis Rheum (1973) 1.63
Immunological enhancement: a study of blocking antibodies. Adv Immunol (1972) 1.59
Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1969) 1.58
Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement. J Immunol (1972) 1.33
Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res (1973) 1.23
Impaired mixed leucocyte reaction in some different diseases, notably multiple sclerosis and various arthritides. Clin Exp Immunol (1971) 1.20
Characterization of a serum inhibitor of MLC reactions. Clin Exp Immunol (1973) 1.14
Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma. Transplant Proc (1973) 1.07
Inhibition of the mixed lymphocyte culture response by antibody following successful human renal transplantation. Tissue Antigens (1971) 1.06
Decreased reactivity of lymphocytes in mixed-leukocyte culture from patients with rheumatic fever. Circulation (1972) 0.95
Lymphocyte inclusions in newborns of mothers with systemic lupus erythematosus. N Engl J Med (1974) 0.86
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature (1985) 2.29
Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones. Nature (1984) 1.96
Rearrangement and expression of the alpha, beta, and gamma chain T cell receptor genes in human thymic leukemia cells and functional T cells. J Exp Med (1986) 1.62
Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells. Transplantation (2000) 1.60
Graft hemostasis: an alternative to preclotting. Ann Thorac Surg (1979) 1.54
Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol (1998) 1.44
Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995. J Thorac Cardiovasc Surg (1999) 1.34
Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA D and with 50 per cent penetrance. N Engl J Med (1977) 1.33
Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med (1993) 1.31
Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J Immunol (1998) 1.30
Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest (1998) 1.30
A ten-year experience with bacterial aortitis. J Vasc Surg (1989) 1.28
The role of anti-HLA antibodies in heart transplantation. Transplantation (1991) 1.27
Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res (1973) 1.23
Cholecystectomy with drainage. Factors influencing wound infection in 1,000 elective cases. Am J Surg (1978) 1.23
Ultrastructure and transmembrane potentials of cardiac muscle in the human anterior mitral valve leaflet. Circulation (1979) 1.21
T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J Immunol (1999) 1.17
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Editorial. Anthropology and genetic markers. Hum Immunol (2001) 1.14
DRw determinants on human T cells primed against allogeneic lymphocytes. Transplant Proc (1978) 1.12
T cell recognition of allopeptides in context of syngeneic MHC. J Immunol (1992) 1.11
Goodpasture's syndrome. Cessation of pulmonary hemorrhage after bilateral nephrectomy. Ann Intern Med (1967) 1.10
Hepatobiliary complications of polyarteritis nodosa. Arch Surg (1991) 1.09
Some theoretic aspects of vascular degeneration. Am J Surg (1970) 1.09
Correction of coarctation of the aorta. Manometric determination of safety during test occlusion. J Thorac Cardiovasc Surg (1971) 1.08
Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol (1993) 1.08
T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules. J Exp Med (1992) 1.06
Counterpulsation with a new pulsatile assist device (PAD) in open-heart surgery. Med Instrum (1976) 1.06
Inhibition of cellular mediated immunity in marihuana smokers. Science (1974) 1.05
Presence of T-cell receptor mRNA in functionally distinct T cells and elevation during intrathymic differentiation. Nature (1984) 1.05
Tertiary hyperparathyroidism following successful renal allografting. Ann Surg (1970) 1.04
Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J Immunol (1993) 1.03
The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. Transplantation (1990) 1.03
Cost-effectiveness of coronary artery bypass surgery in octogenarians. Ann Surg (1998) 1.02
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01
Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci U S A (1983) 1.00
The HLA system in the families of patients with juvenile diabetes mellitus. J Exp Med (1976) 0.98
Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft. Science (1984) 0.97
Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys. Transplantation (1989) 0.97
Effect of recipient gender and race on heart and kidney allograft survival. Transplant Proc (1992) 0.95
Pancreatic islet isografts, allografts, and xenografts: comparison of morphology and function. Surgery (1976) 0.95
Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery (1985) 0.95
Tissue culture preservation and intramuscular transplantation of pancreatic islets. Surgery (1978) 0.94
Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery (1989) 0.94
A regional project in hemodialysis and transplantation. Arch Surg (1970) 0.94
Letter: Cellular immune responsiveness in cigarette smokers. Lancet (1974) 0.94
Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med (1987) 0.94
Juvenile diabetes mellitus and the HLA system. Transplant Proc (1979) 0.94
Elevated pulmonary vascular resistance and cardiac transplantation. Circulation (1987) 0.94
Pancreatic islet allograft prolongation by donor-specific blood transfusions treated with ultraviolet irradiation. Science (1983) 0.93
Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture. J Exp Med (1982) 0.93
Factors influencing patency of femoropopliteal artery bypass grafts. Am J Surg (1976) 0.93
Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. Transpl Immunol (2008) 0.92
MHC class II binding of peptides derived from HLA-DR 1. J Immunol (1992) 0.92
Renal heterotransplantation from nonhuman primates to man. Ann N Y Acad Sci (1969) 0.91
Intraoperative unidirectional intra-aortic balloon pumping in the management of left ventricular power failure. J Thorac Cardiovasc Surg (1975) 0.91
Immunological monitoring of heart allograft recipients. Transplant Proc (1987) 0.91
New perspectives on immunointervention in autoimmune diseases. Immunol Today (1990) 0.90
Cardiac transplantation for patients requiring mechanical circulatory support. N Engl J Med (1978) 0.90
CD8(+)CD28(-) T suppressor cells represent a distinct subset in a heterogeneous population. Transplant Proc (2001) 0.89
Pancreatic transplantation in diabetic rats: renal function, morphology, ultrastructure, and immunohistology. Surgery (1975) 0.89
Mechanism of liver allograft rejection: the indirect recognition pathway. Hum Immunol (1997) 0.89
Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation (1996) 0.89
Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum Immunol (1999) 0.88
Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. Blood (1997) 0.88
A late-differentiation antigen associated with the helper inducer function of human T cells. Nature (1986) 0.88
Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum Immunol (1998) 0.88
Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol (1995) 0.88
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl Immunol (2007) 0.88
Cardiac heterotransplantation. Morphological and immunohistological studies. Transplantation (1975) 0.87
Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant (1992) 0.87
Anti-idiotypic antibodies to HLA-DR4 and DR2. J Immunol (1983) 0.86
New approaches to specific immunomodulation in transplantation. Int Rev Immunol (1996) 0.86
Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance. Immunol Res (1989) 0.86
New HLA-D alleles associated with DR1 and DR2. Tissue Antigens (1981) 0.86
Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens. Nature (1984) 0.86
The accuracy of CT scanning in the diagnosis of abdominal and thoracoabdominal aortic aneurysms. J Vasc Surg (1991) 0.86
Characterization of mononuclear cell infiltrates in human cardiac allografts. Transplant Proc (1984) 0.86
Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells. Am J Transplant (2006) 0.86
Indications for subtotal parathyroidectomy in patients with renal transplantation. Ann Surg (1969) 0.85
Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc (1993) 0.85
Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins. Blood (1996) 0.84
Prolongation of rat heart allografts by donor pretreatment with immunosuppressive agents. Transplant Proc (1971) 0.84
The immunologic and ultrastructural characterization of the cellular infiltrate in acute cardiac allograft rejection: prevalence of cells with the natural killer (NK) phenotype. Clin Immunol Immunopathol (1983) 0.84
Polymorphism of HLA in the Romanian population. Tissue Antigens (1992) 0.84
Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation (1999) 0.83
Intra-HLA recombinations in juvenile diabetes mellitus. Diabete Metab (1977) 0.83
Mechanisms of immunologic unresponsiveness induced by ultraviolet-irradiated donor-specific blood transfusions and peritransplant cyclosporine. Transplantation (1988) 0.83
Xenotransplantation of piscine islets into hyperglycemic rats. Surgery (1975) 0.82